Global Fesoterodine Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 4355

Fesoterodine (INN, used as the fumarate under the brand name Toviaz) is an antimuscarinic drug developed by Schwarz Pharma AG to treat overactive bladder syndrome (OAB).
In 2018, the global Fesoterodine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Fesoterodine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Fesoterodine development in United States, Europe and China.

The key players covered in this study
Pfizer
Amerigen Pharmaceuticals
SANDOZ
LUPIN
Dr. Reddy's Laboratories
Lupin
Amneal Pharmaceuticals
Aurobindo Pharma
Sun Pharmaceutical
Accord Healthcare

Market segment by Type, the product can be split into
4 mg Tablet
8 mg Tablet

Market segment by Application, split into
Hospital
Drug store

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Fesoterodine status, future forecast, growth opportunity, key market and key players.
To present the Fesoterodine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Fesoterodine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Fesoterodine Market Size Growth Rate by Type (2014-2025)
1.4.2 4 mg Tablet
1.4.3 8 mg Tablet
1.5 Market by Application
1.5.1 Global Fesoterodine Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Drug store
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Fesoterodine Market Size
2.2 Fesoterodine Growth Trends by Regions
2.2.1 Fesoterodine Market Size by Regions (2014-2025)
2.2.2 Fesoterodine Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Fesoterodine Market Size by Manufacturers
3.1.1 Global Fesoterodine Revenue by Manufacturers (2014-2019)
3.1.2 Global Fesoterodine Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Fesoterodine Market Concentration Ratio (CR5 and HHI)
3.2 Fesoterodine Key Players Head office and Area Served
3.3 Key Players Fesoterodine Product/Solution/Service
3.4 Date of Enter into Fesoterodine Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Fesoterodine Market Size by Type (2014-2019)
4.2 Global Fesoterodine Market Size by Application (2014-2019)

5 United States
5.1 United States Fesoterodine Market Size (2014-2019)
5.2 Fesoterodine Key Players in United States
5.3 United States Fesoterodine Market Size by Type
5.4 United States Fesoterodine Market Size by Application

6 Europe
6.1 Europe Fesoterodine Market Size (2014-2019)
6.2 Fesoterodine Key Players in Europe
6.3 Europe Fesoterodine Market Size by Type
6.4 Europe Fesoterodine Market Size by Application

7 China
7.1 China Fesoterodine Market Size (2014-2019)
7.2 Fesoterodine Key Players in China
7.3 China Fesoterodine Market Size by Type
7.4 China Fesoterodine Market Size by Application

8 Japan
8.1 Japan Fesoterodine Market Size (2014-2019)
8.2 Fesoterodine Key Players in Japan
8.3 Japan Fesoterodine Market Size by Type
8.4 Japan Fesoterodine Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Fesoterodine Market Size (2014-2019)
9.2 Fesoterodine Key Players in Southeast Asia
9.3 Southeast Asia Fesoterodine Market Size by Type
9.4 Southeast Asia Fesoterodine Market Size by Application

10 India
10.1 India Fesoterodine Market Size (2014-2019)
10.2 Fesoterodine Key Players in India
10.3 India Fesoterodine Market Size by Type
10.4 India Fesoterodine Market Size by Application

11 Central & South America
11.1 Central & South America Fesoterodine Market Size (2014-2019)
11.2 Fesoterodine Key Players in Central & South America
11.3 Central & South America Fesoterodine Market Size by Type
11.4 Central & South America Fesoterodine Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Fesoterodine Introduction
12.1.4 Pfizer Revenue in Fesoterodine Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Amerigen Pharmaceuticals
12.2.1 Amerigen Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Fesoterodine Introduction
12.2.4 Amerigen Pharmaceuticals Revenue in Fesoterodine Business (2014-2019)
12.2.5 Amerigen Pharmaceuticals Recent Development
12.3 SANDOZ
12.3.1 SANDOZ Company Details
12.3.2 Company Description and Business Overview
12.3.3 Fesoterodine Introduction
12.3.4 SANDOZ Revenue in Fesoterodine Business (2014-2019)
12.3.5 SANDOZ Recent Development
12.4 LUPIN
12.4.1 LUPIN Company Details
12.4.2 Company Description and Business Overview
12.4.3 Fesoterodine Introduction
12.4.4 LUPIN Revenue in Fesoterodine Business (2014-2019)
12.4.5 LUPIN Recent Development
12.5 Dr. Reddy's Laboratories
12.5.1 Dr. Reddy's Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 Fesoterodine Introduction
12.5.4 Dr. Reddy's Laboratories Revenue in Fesoterodine Business (2014-2019)
12.5.5 Dr. Reddy's Laboratories Recent Development
12.6 Lupin
12.6.1 Lupin Company Details
12.6.2 Company Description and Business Overview
12.6.3 Fesoterodine Introduction
12.6.4 Lupin Revenue in Fesoterodine Business (2014-2019)
12.6.5 Lupin Recent Development
12.7 Amneal Pharmaceuticals
12.7.1 Amneal Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Fesoterodine Introduction
12.7.4 Amneal Pharmaceuticals Revenue in Fesoterodine Business (2014-2019)
12.7.5 Amneal Pharmaceuticals Recent Development
12.8 Aurobindo Pharma
12.8.1 Aurobindo Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Fesoterodine Introduction
12.8.4 Aurobindo Pharma Revenue in Fesoterodine Business (2014-2019)
12.8.5 Aurobindo Pharma Recent Development
12.9 Sun Pharmaceutical
12.9.1 Sun Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Fesoterodine Introduction
12.9.4 Sun Pharmaceutical Revenue in Fesoterodine Business (2014-2019)
12.9.5 Sun Pharmaceutical Recent Development
12.10 Accord Healthcare
12.10.1 Accord Healthcare Company Details
12.10.2 Company Description and Business Overview
12.10.3 Fesoterodine Introduction
12.10.4 Accord Healthcare Revenue in Fesoterodine Business (2014-2019)
12.10.5 Accord Healthcare Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details